Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

Steven A. Edmundowicz MD, MASGE Associate Editor

Scott J. Cotler MD Associate Editor

See All Experts

featured

Published in Gastroenterology

Journal Scan / Research · September 05, 2024

Assessing Dietary Emulsifier Exposure Among Patients With IBD vs Healthy Controls

Inflammatory Bowel Diseases

Save Recommend

Sign in to PracticeUpdate

Only registered members have full access to PracticeUpdate content.

Not a member?

Join for free

Disclosure statements are available on the authors' profiles:

Amar Naik MD

Inflammatory Bowel Diseases

Dietary Emulsifier Exposure in People With Inflammatory Bowel Disease Compared With Healthy Controls: Is There a Cause for Concern?

Inflamm. Bowel Dis. 2024 Aug 01;30(8)1241-1250, N Katsoudas, P Tavakoli, N Wu, A Shapiro, ST Leach, AJ Williams, R Paramsothy, S Ghaly, SJ Connor, D Samocha-Bonet, K Lambert, GL Hold

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Assessing Dietary Emulsifier Exposure Among Patients With IBD vs Healthy Controls

Additional Info

Dietary Emulsifier Exposure in People With Inflammatory Bowel Disease Compared With Healthy Controls: Is There a Cause for Concern?

Further Reading

M1 and M2 Macrophages Have Different Effects in Regulating Colonic Crypt Renewal

Risk of Recurrence in Screen- vs Non–Screen-Detected Colorectal Cancer

Use of Immunotherapy in the Management of Hepatocellular Carcinoma in the Pre–Liver Transplantation Population

Sphincterotomy for Biliary Sphincter of Oddi Disorder and Idiopathic Acute Recurrent Pancreatitis

Impact of Sarcopenia and Myosteatosis on Outcomes in Patients With Cirrhosis

Identifying Baseline Serum and Stool Microbiome Biomarkers Predicting the Outcomes of Ritlecitinib Induction Therapy in Patients With Ulcerative Colitis

Safety and Efficacy of Continuous Terlipressin Infusion for the Management of Hepatorenal Syndrome–Acute Kidney Injury in a Liver Transplantation Population

Changes in Liver Stiffness Measurement Values Are Independently Associated With the Risk of Liver-Related Events in Patients With NAFLD

Benefit of Prophylactic Pancreatic Stent Placement During High-Risk ERCP: Technical Factors

Stool-Based Testing for Post-Polypectomy Colorectal Cancer Surveillance

Efficacy and Safety of Bulevirtide Monotherapy Through 96 Weeks Among Patients With Chronic Hepatitis Delta Virus

Recently Updated